Intelligence Profile
Research Papers
Exemestane is an aromatase inhibitor primarily used in the treatment of breast cancer. Recent research has explored various aspects of its application and effects.
A phase II study published in "Gynecologic Oncology" (PMID: 42574969) evaluated exemestane in combination with darolutamide and leuprolide acetate for ovarian granulosa cell tumors. This study highlights potential new therapeutic applications for exemestane beyond breast cancer.
Another study, "Development and characterization of an injectable thermoresponsive PLGA nanoparticle-loaded in situ gel for sustained exemestane delivery," published in "Frontiers in Oncology" (PMID: 42564046), focused on creating a sustained-release formulation for exemestane. This could improve drug delivery and patient compliance.
A pharmacovigilance study (PMID: 42541454) explored the hepatotoxicity associated with aromatase inhibitors, including exemestane, using a Bayesian network and frequentist metrics. This study underscores the importance of monitoring liver function during exemestane therapy.
Another study in "Frontiers in Oncology" (PMID: 42482750) investigated tendon toxicity linked to aromatase inhibitors like exemestane. This real-world data is crucial for managing side effects in clinical practice.
The journal "The Journal of Steroid Biochemistry and Molecular Biology" presented findings on exemestane-induced cardiotoxicity (PMID: 42447938). Chronic exposure can disrupt calcium homeostasis and the endothelin pathway, providing evidence of potential cardiovascular risks.
Clinical trials also offer extensive insights into exemestane's efficacy. A completed phase 3 trial (NCT00002777) compared exemestane and tamoxifen in treating recurrent or metastatic breast cancer, helping to refine treatment protocols.
Overall, while there is significant research on exemestane's applications and safety concerns, continuing studies will further clarify its benefits and risks.
Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider for medical guidance.